Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non-small cell lung cancer.
Osamu KanaiTakanori ItoZentaro SaitoYuki YamamotoKohei FujitaMisato OkamuraMasayuki HashimotoKoichi NakataniSatoru SawaiTadashi MioPublished in: Thoracic cancer (2021)
There was no additional or negative impact of COX-I use on the efficacy of ICIs in NSCLC.